Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
Cash from Investing Activities
Heidelberg Pharma AG
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Heidelberg Pharma AG
XETRA:HPHA
|
Cash from Investing Activities
€5.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Investing Activities
-€7B
|
CAGR 3-Years
-263%
|
CAGR 5-Years
-154%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Investing Activities
€15.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Investing Activities
-€31.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Cash from Investing Activities
€1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Cash from Investing Activities
-€37.1m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
-136%
|
CAGR 10-Years
N/A
|
See Also
What is Heidelberg Pharma AG's Cash from Investing Activities?
Cash from Investing Activities
5.8m
EUR
Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's Cash from Investing Activities amounts to 5.8m EUR.